|
Lab Resource and Marketplace Search
>
Sort By
|
Agilent’s Infinity range of LC systems have a latest addition in the form of new 1260 Infinity Multi-Detector Bio-SEC solution for biopharmaceutical industry. This new size exclusion chromatography (SEC) system is a state of the art, completely bio-inert, high resolution system with high sensitivity forRead more… 
HORIBA Scientific is announcing the launch of XploRA™ PLUS, a compact Raman spectrometer that compromises on space but does not compromise on image resolution, data quality and reliability for multi-sample detection. Announced at PITTCON, the XploRA™ PLUS is a high performance and fully confocal RamanRead more… 
University of Chicago’s Supercomputer Beagle has demonstrated that it is possible to process 240 whole human genomes in less than 48 hour. This was done using just 1/4th of Beagle’s processing power. While other cloud computing giants such as Amazon and Google are jumping onRead more… 
Researchers from the Gladstone Institute of Cardiovascular Disease and the University of California in San Francisco have recently found a quicker way to boost the introduction and/or identification of rare mutations in the human genome without compromising its integrity. Bruce Conklin and coworkers describe theirRead more… 
An Oxford Instruments company, Asylum Research, develops an improved atomic force microscopy (AFM) technique known as the Scanning Microwave Impedance Microscopy (sMIM). This technique not only provides nanomechanical and nanoelectrical information but also allows nanoscale mapping of permittivity (capacitance) and conductivity (resistance) with higher resolutionRead more… 
Researchers are now able to develop transfection-based assays in various cell lines with the launching of Promega Corporation’s ViaFect Transfection Reagent. This reagent has proven higher transfection efficiency and lower toxicity, allowing cells to remain viable and metabolically active throughout the transfection process. Studies haveRead more… 
The new ISOLUTE PLD+ offers a very simple and effective sample clean-up for LC-MS/MS analysis in a single product. These plates have a scavenging sorbent layer that removes phospholipids during the filtration step. These plates, available in standard SBS/ANSI 96 well plate format are capable of processing sample volumes of 100 to 200 microliters and they can remove more than 99 percent of plasma proteins and phospholipids. Removal of phospholipids prevents it from building up in the analytical column, thereby increasing its life and maintaining analyte sensitivity over extended analytical runs. This results in cleaner extracts and increased signal to noise ratio and sensitivity for a wide range of analytes. Biotage ISOLUTE PLD+ can be easily integrated into the routine workflow in no time without any method development and the purified samples can be analysed directly without any further processing. These ISOLUTE PLD+ plates are compatible with positive pressure manifolds, vacuum manifolds and also automated liquid handling systems that can handle 96 well format. Source: Biotage It is always a pain to analyse blood based matrix samples using LC-MS/MS as the plasma proteins and phospholipids in sample causes ion suppression. Biotage has come with a solution for this issue by launching a protein and phospholipid removal plate, ISOLUTE PLD+ for clean-upRead more… 
Syngene has launched the latest G:BOX Chemi XRQ multifunctional imaging system with latest imaging technology and software to replace its earlier G:BOX Chemi XR5 System. The new system is capable of quick and efficient imaging of a wide range of gel and blot types inRead more…  Engineers at the University of Washington synthesized nanoparticles using an engineered protein to improve vaccine production and administration. Moving from attenuated or killed pathogens to protein-based subunit vaccines which are usually formulated with adjuvants, the researchers developed a calcium phosphate core-immunogen shell nanoparticle to exploit the potential of nanoparticles as effective delivery vehicles.
The development of these nanoparticles is not only useful for viral infections that are hard to vaccinate against, but also overcomes issues concerning the cold chain in vaccine manufacturing and distribution. Although only proven in mice, with further studies and investigations, the development of vaccines using this technique would greatly benefit the human populations especially during disease outbreaks. Source: University of Washington Engineers at the University of Washington synthesized nanoparticles using an engineered protein to improve vaccine production and administration. Moving from attenuated or killed pathogens to protein-based subunit vaccines which are usually formulated with adjuvants, the researchers developed a calcium phosphate core-immunogen shell nanoparticle to exploitRead more… 
A group of chemists led by Jan van Hest from the Institute for Molecules and Materials at Radboud University Nijmegen have developed a living cell out of plastic. This new artificial cell contains organelles that can carry out a number of chemical reactions. Cells areRead more… |
